Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Biliary Tract Adenocarcinoma × HMPL-013 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 15 Stomach Neoplasms 5 Rectal Neoplasms 2 Advanced Colorectal Carcinoma 2 Unresectable Metastatic Colorectal Cancer 1 TAS 102 1 Patients With Advanced Metastatic Colorectal Cancer 1 Pancreatic Neoplasms 1 Metastasis Colorectal Cancer 1 Locally Advanced Rectal Cancer 1 HER2-positive Gastric Cancer 1 Esophageal Squamous Cell Carcinoma 1 Colorectal Adenocarcinoma 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Biliary Tract Adenocarcinoma 1

Interventions

toripalimab 1 donafenib 1 Oxaliplatin 1 HMPL-013 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04156958 2019-11-08

FSTAMBTA

Sichuan University

Phase 2 Unknown

Gastrointestinal

Biliary Tract Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡